{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:52:43Z","timestamp":1790229163681,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Hochschule Hannover (MHH)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Drug advertising primarily serves to publicize the product and increase sales. The legal requirements in the Therapeutic Products Advertising Act (Heilmittelwerbegesetz, HWG) in Germany\u00a0are intended to protect consumers. However, a lack of information about the potential\u00a0negative aspects of drugs represents a risk for viewers. In this study, we analyzed a total of 52 advertising clips for drugs, food supplements, and medical products on public and private German television. These short films in the commercial breaks between the TV programs serve to publicize and advertise products. Furthermore, the corresponding package inserts for the drugs and the content and structure of the advertising clips were analyzed. The clips were compared with each other as well as about the mandatory information according to \u00a74 of the HWG and \u00a711 of the Medicinal Products Act (Arzneimittelgesetz, AMG). The study revealed that a large proportion of the mandatory information was not included in the advertising clips analyzed. Not all legal requirements were met in the package inserts either. Alarmingly, the advertising clips consistently contained only one of the mandatory information pieces, namely, the name of the product. Adverse effects were not mentioned in any advertising clip, and the effects of drugs were only poorly explained, if at all. Overall, scientific content of the advertisements was minimal if at all present. Instead, the airtime was dominated by emotional and attention-grabbing content in the form of a frame story, whereas the potential to educate people about medicines and raise public awareness remains mostly unused. Thus, drug advertisements on German television exhibit substantial scientific and legal deficiencies. In addition, we noted several legal gray zones in advertisements. The deficiencies in drug advertisement quality on television are, unfortunately, in line with quality deficiencies on drug advertisements in various other platforms (see., e.g., <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37792047\/\" ext-link-type=\"uri\">https:\/\/pubmed.ncbi.nlm.nih.gov\/37792047\/<\/jats:ext-link>; <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38430230\/\" ext-link-type=\"uri\">https:\/\/pubmed.ncbi.nlm.nih.gov\/38430230\/<\/jats:ext-link>). Thus, the lack of rigorous implementation of the HWG is a general problem in Germany. We make specific suggestions on what actions should be taken to improve the implementation of the HWG in television advertisements to improve drug safety and consumer safety. <\/jats:p>","DOI":"10.1007\/s00210-024-03604-8","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T09:34:25Z","timestamp":1731663265000},"page":"5287-5301","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Legal and scientific deficiencies of drug advertisements on German television"],"prefix":"10.1007","volume":"398","author":[{"given":"Malin","family":"Philipp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,15]]},"reference":[{"key":"3604_CR1","unstructured":"Appinio (2020) Appinio corona report. Retrieved August 22, 2023, from https:\/\/www.appinio.com\/hubfs\/Coronavirus-Studie\/Corona%20-%20Consumer%20Report%20Tracking%20von%20Appinio%20Welle%2036.pdf?hsCtaTracking=ee6638cb-0141-4976-a019-889b11977254%7C903af145-a21b-4787-8090-3ba76b09833e"},{"key":"3604_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-024-03370-7","author":"L Barlage","year":"2024","unstructured":"Barlage L, Seifert R (2024) Insufficient compliance of the German Therapeutic Products Advertising Act in product catalogues of online pharmacies. Naunyn-Schmiedeberg\u2019s Archives of Pharmacology. https:\/\/doi.org\/10.1007\/s00210-024-03370-7","journal-title":"Naunyn-Schmiedeberg\u2019s Archives of Pharmacology"},{"key":"3604_CR3","unstructured":"Blasius H (2014) Packungsbeilage\u2014Fachinformation. DAZ.online. Retrieved September 12, 2023, from https:\/\/www.deutsche-apotheker-zeitung.de\/daz-az\/2014\/daz-42-2014\/packungsbeilage-fachinformation"},{"key":"3604_CR4","unstructured":"Bruchmann F, N\u00e4gelein P (2018) ZU WENIG KONSEQUENZ IM UMGANG MIT NEBENWIRKUNGEN. Retrieved August 22, 2023, from https:\/\/www.nebenwirkungen.de\/wp-content\/uploads\/2020\/01\/Whitepaper_Nebenwirkungen.de_.pdf"},{"key":"3604_CR5","unstructured":"Bundesministerium der Justiz (2023) Gesetz \u00fcber die Werbung auf dem Gebiete des Heilwesens (Heilmittelwerbegesetz\u2014HWG). Retrieved August 22, 2023, from https:\/\/www.gesetze-im-internet.de\/heilmwerbg\/BJNR006049965.html"},{"key":"3604_CR6","unstructured":"Bundesministerium der Justiz OJ (2022) Gesetz \u00fcber den Verkehr mit Arzneimitteln (Arzneimittelgesetz\u2014AMG) \u00a7 11 Packungsbeilage. Abgerufen 11. Oktober 2022, von. Retrieved August 22, 2023, from https:\/\/www.gesetze-im-internet.de\/amg_1976\/__11.html"},{"key":"3604_CR7","unstructured":"Doormann B (2003) Werbegestaltungundihre Wirkung bei Radio- und TV-Spots. Retrieved August 22, 2023, from https:\/\/www.ard-media.de\/fileadmin\/user_upload\/media-perspektiven\/pdf\/2004\/04-2004_Fodi.pdf"},{"key":"3604_CR8","unstructured":"Ewert K (2020) Pharmaindustrie: Marketing-Strategien. Retrieved August 22, 2023, from https:\/\/www.planet-wissen.de\/gesellschaft\/medizin\/pharmaindustrie\/pharmaindustrie-marketingstrategien-100.html"},{"key":"3604_CR9","unstructured":"Gans S (2024) TV-Tagesablauf. Retrieved October 26, 2024, from https:\/\/www.ard-media.de\/marktdaten\/tv-markt\/tv-tagesablauf"},{"key":"3604_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-023-02744-7","author":"L Keuper","year":"2023","unstructured":"Keuper L, Seifert R (2023) Drug advertising in the German free-of-charge health magazine Apotheken Umschau (Pharmacy review): a critical analysis. Naunyn-Schmiedeberg\u2019s Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-023-02744-7","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"3604_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-024-03401-3","author":"K Kuschel","year":"2024","unstructured":"Kuschel K, Seifert R (2024) Advertisements for prescription-free drugs and dietary supplements in professional journals: a case study on the Deutsche Apotheker Zeitung (German Pharmacy Journal). Naunyn-Schmiedeberg\u2019s Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-024-03401-3","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"3604_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-024-03005-x","author":"H Leemhuis","year":"2024","unstructured":"Leemhuis H, Seifert R (2024) Prescriptions of homeopathic remedies at the expense of the German statutory health insurance from 1985 to 2021: scientific, legal and pharmacoeconomic analysis. Naunyn-Schmiedeberg\u2019s Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-024-03005-x","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"3604_CR13","unstructured":"Madelmond J (2023) Werbung im Fernsehen. Werbung im Fernsehen. Retrieved August 21, 2023, from https:\/\/www.lmz-bw.de\/medienbildung\/themen-von-f-bis-z\/werbung\/werbung-im-fernsehen"},{"key":"3604_CR14","unstructured":"Mantel U (2022) Nur ProSieben noch unter 50: So alt ist das Publikum der Sender. DWDL.De. Retrieved November 9, 2023, from https:\/\/www.dwdl.de\/magazin\/89032\/nur_prosieben_noch_unter_50_so_alt_ist_das_publikum_der_sender\/"},{"key":"3604_CR15","unstructured":"Mitteilungen des Regensburger Verbunds f\u00fcr Werbeforschung (2014) Schwerpunkt: Werbung und Medizin. Retrieved August 22, 2023, from https:\/\/epub.uni-regensburg.de\/31508\/1\/Mitteilungen_RVW_2-2014.pdf"},{"key":"3604_CR16","unstructured":"Solmecke C (2015) Werbung im Fernsehen\u2014Wieviel ist rechtlich erlaubt? WBS.LEGAL. Retrieved August 21, 2023, from https:\/\/www.wbs.legal\/medienrecht\/65309werbung-20148\/"},{"key":"3604_CR17","unstructured":"Statista Research Department (2011) Fernsehzuschauer\u2014Durchschnittsalter nach Sender 2011 | Statista. Retrieved November 9, 2023, from https:\/\/de.statista.com\/statistik\/daten\/studie\/183279\/umfrage\/durchschnittsalter-der-fernsehzuschauer-nach-sender\/"},{"key":"3604_CR18","unstructured":"Trommsdorff V, Becker J (2003) Werbegestaltungundihre Wirkung bei Radio- und TV-Spots. Retrieved August 22, 2023, from https:\/\/www.ard-media.de\/fileadmin\/user_upload\/media-perspektiven\/pdf\/2004\/04-2004_Fodi.pdf"},{"key":"3604_CR19","unstructured":"V\u00f6gtli A (2021) PharmaWiki\u2014Arzneimittelwerbung. Retrieved August 22, 2023, from https:\/\/www.pharmawiki.ch\/wiki\/index.php?wiki=Arzneimittelwerbung"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03604-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03604-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03604-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T08:17:21Z","timestamp":1744273041000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03604-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,15]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["3604"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03604-8","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,15]]},"assertion":[{"value":"30 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was conducted according to the guidelines of good scientific practice of the Hannover Medical School () and officially registered as doctoral thesis project for Malin Philipp. The Hannover Medical School follows the guidelines of the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable because publicly available information is used as data source.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"R.S. is the Editor-in-Chief of Naunyn-Schmiedebergs Arch Pharmacol and follows the editorial guidelines of the journal for editors acting as author ().","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}